Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Topical Ruxolitinib Cream for Refractory Cutaneous Dermatomyositis

NCT06857240 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT06857240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06857240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Topical Ruxolitinib Cream for Refractory Cutaneous Dermatomyositis
Lead sponsor
The Cleveland Clinic
Phase
Phase 2
Overall status
Recruiting
Start date
June 1, 2025
Completion date
December 31, 2027
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dermatomyositis